Literature DB >> 20671593

Pleiotropic effects of transforming growth factor-β in hematopoietic stem-cell transplantation.

Stephanie M Coomes1, Bethany B Moore.   

Abstract

Transforming growth factor (TGF)-β is a pleiotropic cytokine with beneficial and detrimental effects posthematopoietic stem-cell transplantation. TGF-β is increased in specific sites postengraftment and can suppress immune responses and maintain peripheral tolerance. Thus, TGF-β may promote allograft acceptance. However, TGF-β is also the central pathogenic cytokine in fibrotic disease and likely promotes pneumonitis. Although TGF-β can enhance leukocyte recruitment and IgA production, it inhibits both innate and adaptive immune cell function and antiviral host defense posthematopoietic stem-cell transplantation. This review will focus on the current understanding of TGF-β biology and the numerous ways it can impact outcomes posttransplant.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20671593      PMCID: PMC2995826          DOI: 10.1097/TP.0b013e3181efd018

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  67 in total

1.  The critical early proinflammatory events associated with idiopathic pneumonia syndrome in irradiated murine allogeneic recipients are due to donor T cell infusion and potentiated by cyclophosphamide.

Authors:  A Panoskaltsis-Mortari; P A Taylor; T M Yaeger; O D Wangensteen; P B Bitterman; D H Ingbar; D A Vallera; B R Blazar
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  Transforming growth factor-beta induces human T lymphocyte migration in vitro.

Authors:  D H Adams; M Hathaway; J Shaw; D Burnett; E Elias; A J Strain
Journal:  J Immunol       Date:  1991-07-15       Impact factor: 5.422

Review 3.  The relevance of transforming growth factor beta 1 in pulmonary injury after radiation therapy.

Authors:  M S Anscher; F M Kong; R L Jirtle
Journal:  Lung Cancer       Date:  1998-02       Impact factor: 5.705

4.  Transforming growth factor type beta induces monocyte chemotaxis and growth factor production.

Authors:  S M Wahl; D A Hunt; L M Wakefield; N McCartney-Francis; L M Wahl; A B Roberts; M B Sporn
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

Review 5.  Transforming growth factor beta in tissue fibrosis.

Authors:  W A Border; N A Noble
Journal:  N Engl J Med       Date:  1994-11-10       Impact factor: 91.245

6.  Transforming growth factor beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer.

Authors:  M S Anscher; W P Peters; H Reisenbichler; W P Petros; R L Jirtle
Journal:  N Engl J Med       Date:  1993-06-03       Impact factor: 91.245

7.  Type I transforming growth factor-beta receptors on neutrophils mediate chemotaxis to transforming growth factor-beta.

Authors:  M E Brandes; U E Mai; K Ohura; S M Wahl
Journal:  J Immunol       Date:  1991-09-01       Impact factor: 5.422

8.  Transforming growth factor-beta 1 mediates mast cell chemotaxis.

Authors:  B L Gruber; M J Marchese; R R Kew
Journal:  J Immunol       Date:  1994-06-15       Impact factor: 5.422

9.  Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium.

Authors:  R M Lyons; J Keski-Oja; H L Moses
Journal:  J Cell Biol       Date:  1988-05       Impact factor: 10.539

10.  Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth.

Authors:  J H Kehrl; L M Wakefield; A B Roberts; S Jakowlew; M Alvarez-Mon; R Derynck; M B Sporn; A S Fauci
Journal:  J Exp Med       Date:  1986-05-01       Impact factor: 14.307

View more
  12 in total

1.  Impaired pulmonary immunity post-bone marrow transplant.

Authors:  Stephanie M Coomes; Leah L N Hubbard; Bethany B Moore
Journal:  Immunol Res       Date:  2011-05       Impact factor: 2.829

2.  Sputum cytokine levels in patients undergoing hematopoietic SCT and comparison with healthy subjects and COPD: a pilot study.

Authors:  C Moermans; C Bonnet; E Willems; F Baron; M Nguyen; M Henket; J Sele; J-L Corhay; Y Beguin; R Louis
Journal:  Bone Marrow Transplant       Date:  2014-07-28       Impact factor: 5.483

3.  Severe gammaherpesvirus-induced pneumonitis and fibrosis in syngeneic bone marrow transplant mice is related to effects of transforming growth factor-β.

Authors:  Stephanie M Coomes; Sara Farmen; Carol A Wilke; Yasmina Laouar; Bethany B Moore
Journal:  Am J Pathol       Date:  2011-09-13       Impact factor: 4.307

4.  In vivo expansion of a CD9+ decidual-like NK cell subset following autologous hematopoietic stem cell transplantation.

Authors:  Ane Orrantia; Enrique Vázquez-De Luis; Gabirel Astarloa-Pando; Iñigo Terrén; Ainhoa Amarilla-Irusta; Diego Polanco-Alonso; Carmen González; Alasne Uranga; Tomás Carrascosa; Juan J Mateos-Mazón; Juan C García-Ruiz; Sergio Callejas; Ana Quintas; Ana Dopazo; Olatz Zenarruzabeitia; Francisco Borrego
Journal:  iScience       Date:  2022-09-28

5.  Polymorphism in TGFB1 is associated with worse non-relapse mortality and overall survival after stem cell transplantation with unrelated donors.

Authors:  Esteban Arrieta-Bolaños; Neema P Mayor; Steven G E Marsh; J Alejandro Madrigal; Jane F Apperley; Keiren Kirkland; Stephen Mackinnon; David I Marks; Grant McQuaker; Julia Perry; Michael N Potter; Nigel H Russell; Kirsty Thomson; Bronwen E Shaw
Journal:  Haematologica       Date:  2015-11-26       Impact factor: 9.941

Review 6.  Blood Platelets as an Important but Underrated Circulating Source of TGFβ.

Authors:  Kamil Karolczak; Cezary Watala
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

7.  TGF-β sensitivity restrains CD8+ T cell homeostatic proliferation by enforcing sensitivity to IL-7 and IL-15.

Authors:  Lisa D S Johnson; Stephen C Jameson
Journal:  PLoS One       Date:  2012-08-06       Impact factor: 3.240

8.  Elevated inflammatory responses and targeted therapeutic intervention in a preclinical mouse model of ataxia-telangiectasia lung disease.

Authors:  Rudel A Saunders; Thomas F Michniacki; Courtney Hames; Hilary A Moale; Carol Wilke; Molly E Kuo; Johnathan Nguyen; Andrea J Hartlerode; Bethany B Moore; JoAnn M Sekiguchi
Journal:  Sci Rep       Date:  2021-02-19       Impact factor: 4.379

9.  Investigation of TGFB1 -1347C>T variant as a biomarker after allogeneic hematopoietic stem cell transplantation.

Authors:  Petra Kövy; Nóra Meggyesi; Lívia Varga; Katalin Balassa; András Bors; László Gopcsa; Melinda Paksi; Árpád Bátai; Eszter Vad; János Sinkó; Attila Tordai; Tamás Masszi; Péter Reményi; Hajnalka Andrikovics
Journal:  Bone Marrow Transplant       Date:  2019-09-16       Impact factor: 5.483

10.  Prostaglandin E2 Production and T Cell Function in Mouse Adenovirus Type 1 Infection following Allogeneic Bone Marrow Transplantation.

Authors:  Mary K McCarthy; Megan C Procario; Carol A Wilke; Bethany B Moore; Jason B Weinberg
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.